PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy

Completed

Conditions studied: Metastatic Renal Cell Carcinoma, Metastatic Melanoma

In brief

The purpose of this registry is to collect information on patients who are receiving treatment with Proleukin in an organized way, and to learn more about patient care during and after treatment.

Key facts

Study ID

NCT01415167

Run by

Prometheus Laboratories

People needed

1690

Starts

2011-08-01

Expected to finish

2018-05-01

Last updated by the study team

2019-06-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years or older
• Must have received at least one course of high dose IL-2 or Proleukin
• Signed informed consent form

You may not qualify if…

• Prior high dose IL-2 or Proleukin therapy

Where it is running

• The University of Arizona Cancer Center — Tucson, Arizona, United States
• Moores UCSD Cancer Center — La Jolla, California, United States
• USC Norris Cancer Center — Los Angeles, California, United States
• Southern California Permanente Medical Group — Riverside, California, United States
• University of Colorado Cancer Center — Aurora, Colorado, United States
• University of Miami — Miami, Florida, United States
• Mount Sinai Medical Center Comprehensive Cancer Center — Miami Beach, Florida, United States
• H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States
• Emory University Winship Cancer Institute — Atlanta, Georgia, United States
• University of Hawaii — Honolulu, Hawaii, United States
• Rush Pres St Lukes Medical Center — Chicago, Illinois, United States
• Loyola University Medical Center — Maywood, Illinois, United States
• Oncology Specialists, SC — Park Ridge, Illinois, United States
• Indiana University Melvin and Bren Simon Center — Indianapolis, Indiana, United States
• University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
• University of Kansas Hospital — Kansas City, Kansas, United States
• The Baton Rouge Clinic, AMC — Baton Rouge, Louisiana, United States
• Johns Hopkins — Lutherville, Maryland, United States
• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
• University of Michigan Health System — Ann Arbor, Michigan, United States
• University of Michigan — Ann Arbor, Michigan, United States
• Barbara Ann Karmanos Cancer Institute — Detroit, Michigan, United States
• University of Minnesota Masonic Cancer Center — Minneapolis, Minnesota, United States
• Saint Louis University Cancer Center — St Louis, Missouri, United States
• Midwest Cancer Center - Legacy — Omaha, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.